Read our update on COVID-19

  • Prescribing
    Information
    • DUEXIS® (ibuprofen and
      famotidine)
    • PENNSAID® (diclofenac sodium
      topical solution) 2% w/w
    • RAYOS® (prednisone)
      delayed-release tablets
  • Medication
    Guide
    • DUEXIS® (ibuprofen and
      famotidine)
    • PENNSAID® (diclofenac sodium
      topical solution) 2% w/w
  • Patient
    Site
    • DUEXIS® (ibuprofen and
      famotidine)
    • PENNSAID® (diclofenac sodium
      topical solution) 2% w/w
    • RAYOS® (prednisone) delayed-release tablets
For U.S. Healthcare Professionals
Horizon Inflammation Care Horizon Inflammation Care
  • HOME
  • MANAGING OA & RA
    • OA Pathophysiology
    • RA Pathophysiology
    • Opioid Considerations
  • TREATMENT CONSIDERATIONS
    • Upper Gastrointestinal Risk
    • Reduced Systemic Exposure
  • TREATMENT OPTIONS
    • DUEXIS® (ibuprofen and
      famotidine)
    • PENNSAID® (diclofenac sodium
      topical solution) 2% w/w
    • RAYOS® (prednisone)
      delayed-release tablets
  • SUPPORT & SERVICES
    • Get Patient Access Support
    • Request a Representative
    • Sign up for Updates
    • Resource Center
REQUEST SAMPLES
Important Safety Information
  • Prescribing Information
    • DUEXIS® (ibuprofen and famotidine)
    • PENNSAID® (diclofenac sodium topical solution) 2% w/w
    • RAYOS® (prednisone) delayed-release tablets
  • Medication Guide
    • DUEXIS® (ibuprofen and famotidine)
    • PENNSAID® (diclofenac sodium topical solution) 2% w/w
  • Patient Site
    • DUEXIS® (ibuprofen and famotidine)
    • PENNSAID® (diclofenac sodium topical solution) 2% w/w
    • RAYOS® (prednisone) delayed-release tablets
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Site Map
  • Contact Us

DUEXIS, HORIZONCARES, HORIZON INFLAMMATION CARE, PENNSAID, RAYOS, and the HORIZON logo are trademarks owned by or licensed to Horizon. All other trademarks are the property of their respective owners.

© 2020 Horizon Therapeutics plc P-XMP-00276 09/20

ATTENTION You are now leaving this educational content and going to a page with information about Horizon Inflammation Care treatment options. ATTENTION You are now leaving this educational content and going to a page with information about Horizon Inflammation Care treatment options.

Leaving Site

Continue